Official UK procurement notice
Lung Cancer Screening - DAP C
Authority: NHS Essex Integrated Care Board (NHS & healthcare)
What is being bought
Published requirement descriptionThe lung cancer screening service is currently delivered by GP Primary Choice (GPPC). They are commissioned across North East Essex and Suffolk, but sub-contract the Suffolk activity to the Suffolk GP federation. This contract was passed to Essex ICB from Suffolk and North East Essex ICB as part of the ICB reorganisations in April 2026. GPPC have delivered the contract since the start of the Lung Cancer Screening Programme in Suffolk and North East Essex. This contract is only focussed on the lung health check component and is not an end-to-end service. After the lung health checks are completed, GPPC refer appropriate patients to ESNEFT for their low dose CT scan.
The model is built on strong relationships across including integration with primary care and acute services. GPPC lead a culture of partnership working across partners and have a great understanding the population of the local population demographics, patients' needs and are part of primary care and neighbourhood development across North East Essex. No concerns have been raised regarding quality of the service and GPPC have been on track with their activity plans for 25/26 and continue to be on track year to date for 26/27. Quality Audit. The provider is a progressive and responsive organisation with good mix of staff and experience. They are currently delivering several other projects in relation to cancer across North East Essex and there are no concerns raised. They have estates embedded within the community and are working closely with the ICB lung cancer programme manager. The provider has a good link and relationships with primary care. There are always patients who are aging into the eligibility criteria and they have good systems in place with GP practices to ensure that they can get the details of patients who are aging in so they can then access the screening programme.
The contract is a cost and volume contract with GPPC paid £41.80 per lung health check carried out and the trajectory for 26/27 is 25,709 health checks. GPPC are also paid to provide a clinical director across Ipswich and North East Essex at £22,260 for 1 PA per week. This means the annual contract value is £1,096,896. This is funded by the cancer alliance and not from the ICB budget.
CPV: Health services · Medical practice services
The lotProcurement structure
single lot · no lot value publishedProcedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 30 Jul 2026, 14:36 BST
- Last source update
- 17 Aug 2026, 16:55 BST
- Authority reference
ACE-0030-2026-ESX- FTS notice number
2026/S 000-078287- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06d7c8Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Wednesday 12th August 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. Written Representation should be sent to: [email protected]
The Decision Maker for this award was the ICB Executive Board.
There were no conflicts of interest declared by individuals making the decision.
All five key criteria were utilised in determining the suitability and continuation of the provider and weighting The weightings have been designed to prioritise the delivery of high-quality lung cancer screening services that improve early cancer diagnosis, reduce health inequalities and support integrated patient pathways, whilst ensuring value for money and delivering wider social benefits. The highest weightings have therefore been assigned to quality, innovation, integration and reducing inequalities, reflecting both local priorities and national ambitions to diagnose a greater proportion of cancers at Stages 1 and 2.
The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard.
Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by Wednesday 12th August 2026. The contract has not yet formally been awarded, this notice serves as an intention to award under PSR. Written Representation should be sent to: [email protected] The Decision Maker for this award was the ICB Executive Board. There were no conflicts of interest declared by individuals making the decision. All five key criteria were utilised in determining the suitability and continuation of the provider and weighting The weightings have been designed to prioritise the delivery of high-quality lung cancer screening services that improve early cancer diagnosis, reduce health inequalities and support integrated patient pathways, whilst ensuring value for money and delivering wider social benefits. The highest weightings have therefore been assigned to quality, innovation, integration and reducing inequalities, reflecting both local priorities and national ambitions to diagnose a greater proportion of cancers at Stages 1 and 2. The provider is satisfying the original contract and will likely satisfy the proposed contract, based on the DAP C assessment to a sufficient standard.
Notice history
2 releases on Find a TenderPublished amendments (1 · 0 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | Text3 · VI | This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be… | This is a Provider Selection Regime (PSR) intention to award notice. The contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. This contract has now been formally awarded using direct award process C. The Decision Maker for this award was the I… |
1 amendment published without a description.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| GP Primary Choice LtdSMELung Cancer Screening | £1,096,896 † | — | Awarded |
Contracts
Lung Cancer Screening · GP Primary Choice LtdSME
- Signed
- 28 Apr 2026
- Value
- £1,096,896
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 2 from abroad | 1 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The Independent Patient Choice and Procurement PanelReview body
Bidders & participating suppliers
1 commercial party on the notice- GP Primary Choice LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.